Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination

OBJECTIVES: To evaluate hematological parameters and thrombotic profiles of healthy individuals who received Pfizer-BioNTech (BNT162b2) vaccines in Saudi Arabia. METHODS: Hematological parameters and the incidence of anti-platelet factor-4 (anti/PF-4) antibodies were evaluated in 40 participants who...

Descripción completa

Detalles Bibliográficos
Autores principales: Algaissi, Abdullah, Alamer, Edrous, Jeraiby, Mohammed, Alomaish, Abeer, Elrhima, Omer, Qumayi, Sultan, Qasir, Naaif A., Areeshi, Halima, Masmali, Asma, Alhazmi, Abdulaziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389887/
https://www.ncbi.nlm.nih.gov/pubmed/35675927
http://dx.doi.org/10.15537/smj.2022.43.6.20220135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389887/
https://www.ncbi.nlm.nih.gov/pubmed/35675927
http://dx.doi.org/10.15537/smj.2022.43.6.20220135

Ejemplares similares